Botanical species · safety record

Passiflora caerulea

The EFSA Compendium of Botanicals holds 3 constituent measurements and 3 adverse-effect records for Passiflora caerulea. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Passiflora caerulea L.

3Constituent measurements
3Safety records
1Cited sources
1Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 1 licensed products naming Passiflora caerulea as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Source material stated

  • Herb top

What the records describe

Constituents measured

  • Harmane alkaloids1
  • Harmine1
  • Harmol1

Plant parts

  • Aerial part of plants6

Preparations

  • Drying (dehydration)3
  • Solvent extraction3

Effect types

  • Neurotoxicity3

Target tissues

  • Neurologic: central nervous system3

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
Harmane alkaloidsAerial part of plantsSolvent extractionChromatographic testsNo resolvable identifier
HarmineAerial part of plantsSolvent extractionChromatographic testsNo resolvable identifier
HarmolAerial part of plantsSolvent extractionChromatographic testsNo resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

EffectTarget tissuePlant partPreparationTest organismTest typeSource
NeurotoxicityNeurologic: central nervous systemAerial part of plantsDrying (dehydration)Rat (as animal)SubchronicNo resolvable identifier
NeurotoxicityNeurologic: central nervous systemAerial part of plantsDrying (dehydration)Rat (as animal)SubchronicNo resolvable identifier
NeurotoxicityNeurologic: central nervous systemAerial part of plantsDrying (dehydration)Rat (as animal)SubchronicNo resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Zacchino, S., Rodriguez, G., Pennachioni, P., Flores, S., Furlan, R., De Duffard, A. M. Evangelista., Duffard, R. Preliminary toxicological study in rats of Passiflora caerulea extracts. Fitoterapia, 1997, vol. 68, no. 3, p. 265-271.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue